Enveric Biosciences, Inc.
through May 4, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 11, 2026 · D | May 4, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,450,017 | $5,000,002 | $3,549,985 |
| Reported amount sold | $1,450,017 | $5,000,002 | $3,549,985 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0000890821-26-000001 · Later SEC source: 0000890821-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $5,000,002
- Reported amount sold
- $5,000,002
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20252 filings
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (4)
-
0000890821-26-000002D · May 4, 2026 · BiotechnologyOffering: $5,000,002Sold: $5,000,002
-
0000890821-26-000001D · Feb 11, 2026 · BiotechnologyOffering: $1,450,017Sold: $1,450,017
-
0000890821-25-000006D · Dec 23, 2025 · BiotechnologyOffering: $106,598Sold: $106,598
-
0000890821-25-000004D · Oct 3, 2025 · PharmaceuticalsSold: $0